Clinical Trial Update: Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating capecitabine for axillary lymph node–positive operable breast cancer; sponsor Guangxi Medical University; trial status curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Guangxi Medical University | Conditions: Stage II Breast Cancer, Stage III Breast Cancer | Phase 2 | Status: UNKNOWN